InsiderTrades

Form 4 for NUVB Nuvation Bio Inc.

Accepted 2026-07-17 18:27:20 ET · period of report 2026-07-15 · accession 0002039891-26-000008 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-07-17 18:27 2026-07-15 NUVB Sauvage Philippe CFO M - OptEx $2.17 +40.0K 54.1K +283% +$86.8K
DM 2026-07-17 18:27 2026-07-15 NUVB Sauvage Philippe CFO M - OptEx $0.00 -40.0K 500.0K -7% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2026-07-15 M A 39,999 $2.17 54,130 D — — (F1) Includes 1,458 shares purchased through the issuer's employee stock purchase plan on May 19, 2026.
2 Common Class A Common Stock 2026-07-15 M A 1 $1.97 54,131 D — — (F1) Includes 1,458 shares purchased through the issuer's employee stock purchase plan on May 19, 2026.
3 Derivative Stock Option (Right to Buy) 2026-07-15 M D 39,999 $0.00 662,333 D $2.17 · — to 2034-10-06 39,999 Class A Common Stock (F2) Option vests as to 25% on the one year anniversary of October 7, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
4 Derivative Stock Option (Right to Buy) 2026-07-15 M D 1 $0.00 499,999 D $1.97 · — to 2035-02-27 1 Class A Common Stock (F3) Option vests as to 25% on the one year anniversary of February 28, 2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.